BCMA/CD3 BsAb Therapy for POEMS Syndrome
NCT07115654
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
10
Enrollment
OTHER
Sponsor class
Conditions
POEMS Syndrome
Interventions
DRUG:
CM336 (BCMA/CD3 bispecific antibody)
Sponsor
Institute of Hematology & Blood Diseases Hospital, China